Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Fleming Fund

    - PMLiVE

    Scientists uncover new drug target in fight against antimicrobial resistance

    The discovery could lead to improved treatments for bacterial infections

    - PMLiVE

    New study highlights global overuse of antibiotics for diverticulitis

    Researchers warn that excessive antibiotic use in diverticulitis increases risk of antimicrobial resistance and unnecessary hospital admissions

    - PMLiVE

    University of Liverpool identifies new class of antibiotic in fight against AMR

    The new antibiotic class targets two of the WHO’s ‘priority pathogens’

    - PMLiVE

    Sanofi and Kling Bio partner to accelerate discovery of neutralising antibodies

    The alliance will centre on Kling’s B cell immortalisation and screening platform Kling-Select

    - PMLiVE

    UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS

    The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

    - PMLiVE

    BioNTech announces £1bn UK investment to boost regional R&D presence

    The UK government has also agreed to award the company a grant of up to £129m

    - PMLiVE

    UK government’s AMR study highlights importance of appropriate antibiotic use

    The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam

    - PMLiVE

    Prime minister unveils UK government’s plans to abolish NHS England

    The move aims to cut waiting times and free up money for front-line services

    - PMLiVE

    AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections

    Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

    - PMLiVE

    UK government launches ‘landmark’ AI breast cancer screening trial

    Approximately 55,000 cases of the disease are diagnosed every year in the UK

    - PMLiVE

    Valneva shares positive phase 3 results for chikungunya vaccine in adolescents

    The company has submitted label extension applications for Ixchiq in this age group

    - PMLiVE

    UK study shows RSV vaccine could reduce antibiotic use and antimicrobial resistance

    The new analysis found that RSV infections lead to 640,000 antibiotic prescriptions every year

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links